Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Colorcon
US Army
Harvard Business School
Cipla
Farmers Insurance
McKinsey
Healthtrust

Generated: May 27, 2018

DrugPatentWatch Database Preview

Invagen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?

INVAGEN PHARMS has fifty-five approved drugs.

There are two tentative approvals on INVAGEN PHARMS drugs.

Summary for Invagen Pharms
US Patents:0
Tradenames:45
Ingredients:45
NDAs:55

Drugs and US Patents for Invagen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 206556-001 Aug 26, 2016 AB3 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Invagen Pharms GEMFIBROZIL gemfibrozil TABLET;ORAL 077836-001 Jul 27, 2006 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Invagen Pharms AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 206367-001 Dec 10, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Invagen Pharms NABUMETONE nabumetone TABLET;ORAL 078671-002 Mar 7, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Baxter
Cantor Fitzgerald
Covington
McKinsey
Citi
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.